PharmaCyte Biotech (PMCB) Return on Sales [ROS] (2010 - 2013)
PharmaCyte Biotech's Return on Sales [ROS] came in at -40488.52% for fiscal Q1 2014 (quarter ended Jul 31, 2013), down 32357.12 percentage points from -8131.39% a year earlier and down 27450.43 percentage points from the prior quarter.
Powered by 
Analysis
PharmaCyte Biotech (PMCB) Return on Sales [ROS] (2010 - 2013) Analysis & Trends
For FY2013 (ended Apr 30, 2013), PharmaCyte Biotech's Return on Sales [ROS] was -13851.65%, down 10923.11 percentage points from FY2012.
- Going back by fiscal year, Return on Sales [ROS] was -2928.55% in FY2012 (-2620.32 pp) and -308.23% in FY2011.
- The fiscal Q1 2014 figure represents the lowest quarterly Return on Sales [ROS] in data going back to fiscal Q1 2011.
- Year-over-year, Return on Sales [ROS] has declined for nine consecutive quarters, with an average year-over-year change of -7967.26 percentage points over the last eight quarters.
- The year-over-year drop in Return on Sales [ROS] has ranged between 1807.74 percentage points (fiscal Q3 2012) and 32357.12 percentage points (fiscal Q1 2014) over the last five years.
- Business Quant data shows PMCB's Return on Sales [ROS] at -13038.09% (Q4 2013), -8733.76% (Q3 2013) and -5547.89% (Q2 2013) in the three fiscal quarters before Q1 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 28.37% |
| 10 | PharmaCyte Biotech | 4.40 Mn | 4.40 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2013 | -40,488.52% |
| Apr 30, 2013 | -13,038.09% |
| Jan 31, 2013 | -8,733.76% |
| Oct 31, 2012 | -5,547.89% |
| Jul 31, 2012 | -8,131.39% |
| Apr 30, 2012 | -7,227.51% |
| Jan 31, 2012 | -2,022.51% |
| Oct 31, 2011 | -2,034.52% |
| Jul 31, 2011 | -3,302.30% |
| Apr 30, 2011 | -432.24% |
| Jan 31, 2011 | -214.77% |
| Oct 31, 2010 | -120.85% |
| Jul 31, 2010 | -294.27% |
API Access
PharmaCyte Biotech Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "PMCB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PMCB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();